Home | About Us | Our Services | Our Clients | Our Expertise | Our Feeds | Sagacious Advantage | Contact Us | Blog

Cipla breached patent rights by slashing drug prices: says Bayer

No Comments »

To read more, Please visit – http://bit.ly/K8xuCu

RyMed Technologies Wins Patent Infringement Case against ICU Medical over Neutral Advantage(TM) technology products

No Comments »

To read more, Please visit – http://on.mktw.net/M3GEo8

Cipla violates patent rights by slashing drug prices: says Bayer

No Comments »


To read more, Please visit – http://bit.ly/LVpTLX

Coloplast Wins Patent Infringement Verdict Against Generic Medical Devices, Inc

No Comments »

To read more, Please visit – http://bit.ly/Ji5CfY

Roche stops Cholesterol Drug Trial On Poor Results

No Comments »


To read more, Please visit – http://on.wsj.com/IBXHYK

An article describing Obviousness and Chemical Compounds

No Comments »

To read more, Please visit – http://bit.ly/J91i6m

Integral Molecular announces patent allowance for Generating Lipoprotein particles

No Comments »

To read more, Please visit – http://bit.ly/IQlBPL

Japanese Patent office grants new patent to Rexahn Pharma for “Quinazoline Derivatives and Therapeutic Use Thereof”

No Comments »

To read more, Please visit – http://on.mktw.net/Ktg6vH

Court Rejects FTC’s Approach to Pay-for-Delay Settlements as “Turducken Task”

No Comments »

To read more, Please visit – http://bit.ly/IZleW1

Indian High Court grants temporary relief to Troikaa Pharmaceutical over Dynapor Injection

No Comments »

To read more, Please visit – http://bit.ly/JM8hA4

Teva & Mylan all set To Resolve Pending Patent Litigation Related To Nuvigil

No Comments »

To read more, Please visit – http://bit.ly/IBr3vj

 Merck won two patent infringement lawsuits against generic drugmaker seeking to make copycat of its lucrative cholesterol pills

No Comments »

To read more, Please visit – http://bit.ly/IwueFx

Teva reaches settlement agreement with pfizer over epinephrine injector

No Comments »

To read more, Please visit – http://bit.ly/JSKWvY

Pfizer & Biocon inks deal of $350 million to market Insulin API

No Comments »

To read more, Please visit – http://bit.ly/Ilbcao

Conceptus(R) Announces Settlement of Patent Infringement Lawsuit With Hologic over Permanent Contraception System

No Comments »

To read more, Please visit – http://yhoo.it/Iip8ru

US Supreme court rules Generic drugmaker may sue over brand patent

No Comments »

To read more, Please visit – http://bit.ly/J3OeKQ

US Judge Upholds Validity Of Merck’s Vytorin Patent for cholesterol lowering drug

No Comments »


To read more, Please visit – http://on.wsj.com/Ie3aWA

Abbott directs FDA to Refuse Certain Biosimilar Applications

No Comments »

To read more, Please visit – http://bit.ly/JmTJUJ

Abbott directs FDA to Refuse Certain Biosimilar Applications

No Comments »


To read more, Please visit – http://bit.ly/JmTJUJ

Catheter Connections sued by Ivera Medical

No Comments »


To read more, Please visit – http://bit.ly/Icpejp

Nestlé wins pricey battle for Pfizer baby food group

No Comments »

To read more, Please visit – http://bit.ly/IyAbPa

Drug companies are in such need of the latest experimental therapies to replace medicines losing patent protection

No Comments »

To read more, Please visit – http://bloom.bg/JkRunp

Law Office of Brodsky & Smith, LLC Announces Investigation of Ardea Biosciences acquisition

No Comments »

To read more, Please visit – http://on.mktw.net/HZrb3K

Nestle to buy Pfizer’s infant-nutrition business for $11.85 billion

No Comments »

To read more, Please visit – http://wapo.st/I5D0cs

Pfizer all set to To Realize Some Speculative Moves

No Comments »

To read more, Please visit – http://bit.ly/JB6QUg

Patents & Earnings Preview of pharma giant Bristol-Myers: A report

No Comments »


To read more, Please visit – http://bit.ly/JAjp2b

Latest lawsuits in the arena of Life-science in last week

No Comments »

To read more, Please visit – http://bit.ly/I2GjNU

A report on BIO Comments on FDA Biosimilars Guidance

No Comments »

To read more, Please visit – http://bit.ly/K9ZzbN

U.S. Supreme Court Restores Generic Pharma’s Ability To Challenge Orange Book Use Code Information

No Comments »

To read more, Please visit – http://bit.ly/Ki7iDX

Dehaier Medical Signs Strategic Cooperation Agreement with Timesco of London Ltd for exclusive distribution of drugs

No Comments »

To read more, Please visit – http://on.mktw.net/IiR5SH

Court Rules In Favor Of Merck In Mylan Litigation over ZETIA and VYTORIN

No Comments »

To read more, Please visit – http://bit.ly/J6mExp

Vivus announces FDA Approval Of STENDRA Tablets

No Comments »

To read more, Please visit – http://bit.ly/Ia9L4x

Pressure BioSciences & Target Discovery Expand Strategic License Agreement to develop Personalized Medicine Clinical Diagnostic Services

No Comments »

To read more, Please visit – http://on.mktw.net/JORE66

Expiring patents may boost up Drug market to 15-34%

No Comments »

To read more, Please visit – http://bit.ly/HNdUgW

Report says Generics, Unemployment Soften Rise In US Drug Spending

No Comments »

To read more, Please visit – http://bit.ly/IyluaB

Indian Pharma giant Piramal Groups set to buy European drug firm to conduct basic phrmaceutical research

No Comments »

To read more, Please visit – http://bit.ly/IvIC9N

Gevo empower its IP Portfolio Rapidly Expanding En Route to Achieving Commercial-Scale Isobutanol Production

No Comments »

To read more, Please visit – http://on.mktw.net/Jd2mmJ

An update on latest proceedings in Dey Pharma, LP v. Sunovion Pharmaceuticals Inc

No Comments »


To read more, Please visit – http://bit.ly/Iq9A5H

Cozen O’Connor Continues Growth of IP Litigation Practice with Seven Partners

No Comments »

To read more, Please visit – http://on.mktw.net/HJ7xHR

Helicos BioSciences to sale its Prenatal Diagnostics IP to Sequenom: A report

No Comments »

To read more, Please visit – http://on.mktw.net/HVRxrN

Court rules in favor of Teva’s Cephalon on Challenge to Amrix Patents

No Comments »

To read more, Please visit – http://buswk.co/HS617Z

Expiring patents may boost up Drug market to 15-34%

No Comments »

To read more, Please visit – http://bit.ly/HNdUgW

Report says Generics, Unemployment Soften Rise In US Drug Spending

No Comments »

To read more, Please visit – http://bit.ly/IyluaB

Indian Pharma giant Piramal Groups set to buy European drug firm to conduct basic phrmaceutical research

No Comments »

To read more, Please visit – http://bit.ly/IvIC9N

A scope for Inventors on Creating new antibiotics

No Comments »

To read more, Please visit – http://bit.ly/HD50CR

Pfizer all set to Plummet On New Quigley Lawsuit Developments

No Comments »

To read more, Please visit – http://bit.ly/JiGjYo

Ironridge BioPharma to Invest $500,000 in Pressure BioSciences

No Comments »

To read more, Please visit – http://on.mktw.net/IAHDpa

Federal Circuit Finds Aventis Patent Unenforceable despite therasense

No Comments »

To read more, Please visit – http://bit.ly/ItvGTH

A case study analysis of SmartGene, Inc. v. Advanced Biological Laboratories SA (D.D.C. 2012)

No Comments »

To read more, Please visit – http://bit.ly/Izyi1n

A report analysing Does Diagnostic Method Claims Fall under the Safe Harbor of 35 U.S.C. § 287©

No Comments »

To read more, Please visit – http://bit.ly/IERFq5

keep looking »